CD4 and ovarian clear cell cancer: In ovarian clear cell carcinoma, ACY-1215 was found to activate CD4 and CD8 T cells and increase IFNγ+ CD4 and CD8 T cells, as a result enhancing the immune killing effect (Fukumoto et al., 2019).